GRL-09510, a Unique P2-Crown-Tetrahydrofuranylurethane -Containing HIV-1 Protease Inhibitor, Maintains Its Favorable Antiviral Activity against Highly-Drug-Resistant HIV-1 Variants in vitro-Reference-Cited by-同舟云学术

GRL-09510, a Unique P2-Crown-Tetrahydrofuranylurethane -Containing HIV-1 Protease Inhibitor, Maintains Its Favorable Antiviral Activity against Highly-Drug-Resistant HIV-1 Variants in vitro

Published:2017-09-25 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Amano Masayuki,Miguel Salcedo-Gómez Pedro,Yedidi Ravikiran S.,Delino Nicole S.,Nakata Hirotomo,Venkateswara Rao Kalapala,Ghosh Arun K.,Mitsuya Hiroaki

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-12052-9.pdf

Reference48 articles.

1. Edmonds, A. et al. The effect of highly active antiretroviral therapy on the survival of HIV-infected children in a resource-deprived setting: a cohort study. PLoS Med. 8, e1001044 (2011).

2. Lohse, N., Hansen, A. B., Gerstoft, J. & Obel, N. Improved survival in HIV-infected persons: consequences and perspectives. J. Antimicrob. Chemother. 60, 461–463 (2007).

3. Mitsuya, H., Maeda, K., Das, D. & Ghosh, A. K. Development of protease inhibitors and the fight with drug-resistant HIV-1 variants. Adv. Pharmacol. 56, 169–197 (2008).

4. Walensky, R. P. et al. The survival benefits of AIDS treatment in the United States. J. Infect. Dis. 194, 11–19 (2006).

5. UNAIDS report on the global epidemic 2013: http://www.unaids.org/en/resources/campaigns/globalreport2013/globalreport

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Machine learning‐guided design of potent darunavir analogs targeting HIV‐1 proteases: A computational approach for antiretroviral drug discovery;Journal of Computational Chemistry;2024-01-04

2. Research Progress in HIV and Mycobacterium tuberculosis Inhibitors Containing Sulfonamide Moiety;Journal of Chemistry;2023-12-07

3. Expanding the therapeutic options for Candida infections using novel inhibitors of secreted aspartyl proteases;Drug Development Research;2022-11-26

4. Combined Pharmacophore Modeling, 3D-QSAR, Molecular Docking and Molecular Dynamics Study on Indolyl-aryl-sulfone Derivatives as New HIV1 Inhibitors;Acta Chimica Slovenica;2022-06-15

5. Fluorine Modifications Contribute to Potent Antiviral Activity against Highly Drug-Resistant HIV-1 and Favorable Blood-Brain Barrier Penetration Property of Novel Central Nervous System-Targeting HIV-1 Protease Inhibitors In Vitro;Antimicrobial Agents and Chemotherapy;2022-02-15